NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study

Clinical trial NCT06269640 · TERMINATED

Trial details

NCT number: NCT06269640
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hypertrophic Cardiomyopathy Left Ventricular Septal Hypertrophy Mitral Valve Disease Aortic Valve Stenosis

Start date: 2024-12-18
Primary completion: 2024-12-23
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.